Suvorexant (Belsomra) for the Treatment of Bipolar Depression With Insomnia

NCT03764683 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study was terminated due to COVID-19.

Conditions

Bipolar Disorder
Insomnia

Interventions

DRUG: Suvorexant (Belsomra)
DRUG: Placebo

Sponsor

Massachusetts General Hospital